P02.21. Short- and long-term effects of expressive writing in patients with renal cell carcinoma

por Cohen, L, Tannir, N, Jonasch, E, Pisters, L, Matin, S, Spelman, A, Wei, Q, Wood, C
Publicado 2012

MicroRNA profiling in clear cell renal cell carcinoma tissues potentially links tumorigenesis and recurrence with obesity

por Shu, X, Hildebrandt, M A, Gu, J, Tannir, N M, Matin, S F, Karam, J A, Wood, C G, Wu, X
Publicado 2017

Vaccination of metastatic renal cell carcinoma patients with autologous tumour-derived vitespen vaccine: clinical findings

por Jonasch, E, Wood, C, Tamboli, P, Pagliaro, L C, Tu, S M, Kim, J, Srivastava, P, Perez, C, Isakov, L, Tannir, N
Publicado 2008

Associations between KIR/KIR-ligand genotypes and clinical outcome for patients with advanced solid tumors receiving BEMPEG plus nivolumab combination therapy in the PIVOT-02 trial

por Feils, A. S., Erbe, A. K., Birstler, J., Kim, K., Hoch, U., Currie, S. L., Nguyen, T., Yu, D., Siefker-Radtke, A. O., Tannir, N., Tolaney, S. M., Diab, A., Sondel, P. M.
Publicado 2023

High-resolution profiling of histone h3 lysine 36 trimethylation in metastatic renal cell carcinoma

por Ho, T H, Park, I Y, Zhao, H, Tong, P, Champion, M D, Yan, H, Monzon, F A, Hoang, A, Tamboli, P, Parker, A S, Joseph, R W, Qiao, W, Dykema, K, Tannir, N M, Castle, E P, Nunez-Nateras, R, Teh, B T, Wang, J, Walker, C L, Hung, M-C, Jonasch, E
Publicado 2016